MPC vs TCRX · P/E 16, rev $86.19B vs rev $2.0M
Marathon Petroleum Corp (MPC) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2026-06-30 was $86.19B. Net income was $5.65B. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the MPC and TCRX stock pages for the full models.
Not investment advice.